
Keywords: ABMR; Antibody mediated rejection; aHUS; Atypical hemolytic syndrome; AP; Alternative pathway; DBD; Deceased brain dead; DCD; Deceased cardiac death; DSA; Donor specific antibodies; C1-INH; C1-inhibitor; C3; Complement component C3; CDC; Complement-depend